Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Godman

Showing results (161-170 of 510) with videos related to

Pageof 51
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|January 28, 2012
Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu DhabiMohammed Abuelkhair, Shajahan Abdu, Brian Godman, et al.
International Journal of Technology Assessment in Health Care|January 16, 2026
Navigating market access after conditional reimbursement: A communication roadmap for disinvesting orphan drugsKhadidja Abdallah, Alessandra Blonda, Brian Godman, et al.
Expert Review of Anti-Infective Therapy|September 20, 2017
Compliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implicationsTammy B Matsitse, Elvera Helberg, Johanna C Meyer, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 25, 2016
The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in PolandTomasz Bochenek, Ewa Kocot, Marcin Rodzinka, et al.
Current Medical Research and Opinion|October 27, 2018
Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implicationsIva Selke Krulichová, Gisbert W Selke, Uwe Eichler, et al.
Frontiers in Pharmacology|April 6, 2026
Factors associated with inappropriate antibiotic use in South African communities: findings from the CAMUS surveyNishana Ramdas, Natalie Schellack, Corrie Uys, et al.
Hospital Pharmacy|January 16, 2023
Adherence to WHO Criteria on Drug Promotion Literature: An Exploratory Study From a Tertiary Healthcare Facility in South-West NigeriaJoseph O Fadare, Iyanu Bankole, Adefunke Babatola, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 14, 2021
Economic and social cost of epilepsy in Poland: 5-year analysisJoanna Jędrzejczak, Beata Majkowska-Zwolińska, Anna Chudzicka-Bator, et al.
Antibiotics (Basel, Switzerland)|January 28, 2026
Psychometric Validation of the Community Antimicrobial Use Scale (CAMUS) in Primary Healthcare and the Implications for Future UseNishana Ramdas, Natalie Schellack, Corrie Uys, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 23, 2018
Cost-effectiveness thresholds: methods for setting and examples from around the worldAndré Soares Santos, Augusto Afonso Guerra-Junior, Brian Godman, et al.
Pageof 51

Showing results (161-170 of 510) with videos related to

Sort By:
Pageof 51
Expert Review of Pharmacoeconomics & Outcomes Research|January 28, 2012
Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu DhabiMohammed Abuelkhair, Shajahan Abdu, Brian Godman, et al.
International Journal of Technology Assessment in Health Care|January 16, 2026
Navigating market access after conditional reimbursement: A communication roadmap for disinvesting orphan drugsKhadidja Abdallah, Alessandra Blonda, Brian Godman, et al.
Expert Review of Anti-Infective Therapy|September 20, 2017
Compliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implicationsTammy B Matsitse, Elvera Helberg, Johanna C Meyer, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 25, 2016
The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in PolandTomasz Bochenek, Ewa Kocot, Marcin Rodzinka, et al.
Current Medical Research and Opinion|October 27, 2018
Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implicationsIva Selke Krulichová, Gisbert W Selke, Uwe Eichler, et al.
Frontiers in Pharmacology|April 6, 2026
Factors associated with inappropriate antibiotic use in South African communities: findings from the CAMUS surveyNishana Ramdas, Natalie Schellack, Corrie Uys, et al.
Hospital Pharmacy|January 16, 2023
Adherence to WHO Criteria on Drug Promotion Literature: An Exploratory Study From a Tertiary Healthcare Facility in South-West NigeriaJoseph O Fadare, Iyanu Bankole, Adefunke Babatola, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 14, 2021
Economic and social cost of epilepsy in Poland: 5-year analysisJoanna Jędrzejczak, Beata Majkowska-Zwolińska, Anna Chudzicka-Bator, et al.
Antibiotics (Basel, Switzerland)|January 28, 2026
Psychometric Validation of the Community Antimicrobial Use Scale (CAMUS) in Primary Healthcare and the Implications for Future UseNishana Ramdas, Natalie Schellack, Corrie Uys, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 23, 2018
Cost-effectiveness thresholds: methods for setting and examples from around the worldAndré Soares Santos, Augusto Afonso Guerra-Junior, Brian Godman, et al.
Pageof 51